Shreya Shambhavi, Harmanjeet Singh, Ganesh Ramaprasad, Murod Khikmatov, Astha Grover, Seth D. Cohen. "Vedolizumab or infliximab: Treatment option in immune checkpoint inhibitor–induced colitis.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.2667